CPC11 A case of C3 bullous dermatosis
Bindi Gaglani,Paola De Mozzi,Sophia Watts
DOI: https://doi.org/10.1093/bjd/ljae090.024
IF: 11.113
2024-06-28
British Journal of Dermatology
Abstract:Abstract A 44-year-old Asian man was seen as an urgent referral in dermatology for insidious-onset multiple pruritic tense serous-filled blisters. These were of varying sizes and occurred over acral sites and the body, sparing mucosal sites. He has a history of eczema as a child, which was in remission now, and no other medical problems and no regular medications. He denied any bowel problems. A punch biopsy showed subepidermal blistering with few eosinophils and a perivascular lymphocytic infiltrate. A perilesional indirect immunofluorescence was negative for IgG, IgM, IgA and C3 initially, and was repeated later to show granular C3 deposition at the basement membrane. Indirect immunofluorescence and enzyme-linked immunosorbent assay were negative, as was as an autoimmune screen including antinuclear antibodies, extractable nuclear antigen, dsDNA and coeliac screen. The condition was very sensitive to oral steroids, with relapse of the condition after slow wean of prednisolone. C3 bullous dermatosis is a rare form of bullous dermatosis first described by Hashimoto et al. in 2016 (Hashimoto T, Tsuruta D, Yasukochi A et al. Granular C3 dermatosis. Acta Derm Venereol 2016; 96: 748–53). Since its initial report, only 21 such patients have been reported in the literature in total. This condition appears to exhibit clinical characteristics resembling dermatitis herpetiformis in the absence of other diagnostic criteria for coeliac disease. It also presents histopathological features marked by subepidermal blister formation, oedema, and liquefaction degeneration accompanied by infiltrations of lymphocytes, eosinophils and neutrophils in varying combinations. Despite its benign disease progression, it demonstrates a positive response to oral dapsone and topical steroids. Additionally, granular deposition of C3 and C5–C9 is observed, while other complement components do not show significant deposition. Notably, there is a slight reduction in the expression of C3 in the epidermis.
dermatology